Pilot study of topical trifluridine for the treatment of acyclovir-resistant mucocutaneous herpes simplex disease in patients with AIDS (ACTG 172). AIDS Clinical Trials Group. (Q53987050)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Pilot study of topical trifluridine for the treatment of acyclovir-resistant mucocutaneous herpes simplex disease in patients with AIDS (ACTG 172). AIDS Clinical Trials Group. |
scientific article |
Statements
Pilot study of topical trifluridine for the treatment of acyclovir-resistant mucocutaneous herpes simplex disease in patients with AIDS (ACTG 172). AIDS Clinical Trials Group. (English)
D R Kuritzkes
H A Kessler
S Hurwitz
C Farthing
C A Benson
J Feinberg
T C Bailey
S Safrin
R T Steigbigel
S H Cheeseman
G F McKinley
B Wettlaufer
S Owens
T Nevin
J A Korvick
1 June 1996
12
2
147-152